News Headlines Article

UCSF, Quest Diagnostics target autism, brain cancer in early ‘precision med’ projects
San Francisco Business Times

UCSF scientists will work with Quest Diagnostics to jointly research, develop and validate diagnostics aimed at building tools that can give doctors and patients a more-precise path for therapy for autism, cancer, neurology and women’s health. Financial terms of the deal were not disclosed, but the University of California, San Francisco, said the master deal initially focuses on two projects already under way with Madison, N.J.-based Quest (NYSE: DGX).